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e.2012.02Abstract Background: Mechanical ventilation offers essential ventilatory support, while the respi-
ratory system recovers from acute respiratory failure. Yet, invasive mechanical ventilation is asso-
ciated with risks and complications that prolong the duration of mechanical ventilation and
increase the risk of death. Neuromuscular dysfunctions acquired during intensive care unit (ICU)
stay are considered to be one of the important factors that impair the weaning process.
The aim of this work: To evaluate the role of the neuromuscular factors responsible for difﬁcult
weaning from mechanical ventilation.
Methods: The study included 19 patients with difﬁcult weaning from mechanical ventilation from
the Alexandria medical respiratory intensive care unit (ICU) during the period from May 2009 till
May 2010. The selected patients included patients who need mechanical ventilation for medical rea-
sons, Patient fulﬁlling the parameters for weaning, (59) with failed spontaneous breathing trial. In
the present study EMG and sensory–motor nerve conduction study was done.
Results: 26% show normal study, 63% showed moderate to severe axonal sensory–motor periph-
eral neuropathy and 11% showed a picture of myopathy. The study revealed that 33% of the
patients with peripheral neuropathy failed weaning trials and ﬁnally died. It is also found that drugsEMG, electromyography
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224 Y. Khalil et al.taken during ICU stay as corticosteroids and electrolyte disturbances (hypocalcaemia, hypophos-
phatemia, and hypomagnesaemia) may be related to the occurrence of neuromuscular dysfunctions.
The present work also revealed a signiﬁcant relationship between hypoalbuminemia and neuromus-
cular dysfunction.
Conclusions: The present study stresses on the importance of neuromuscular assessment in all cases
with difﬁcult weaning as this may be an important contributing factor for difﬁcult weaning and pro-
longed mechanical ventilation (neuropathic or myopathic in origin). EMG and nerve conduction
study may be of help for the detection of such disturbances. So, proper assessment of the neuromus-
cular apparatus and the management of any disorder may be a great step toward successful wean-
ing.
ª 2012 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Mechanical ventilation offers essential ventilatory support,
while the respiratory system recovers from acute respiratory
failure. Yet, invasive mechanical ventilation is associated with
risks and complications that prolong the duration of mechan-
ical ventilation and increase the risk of death.1,2 Therefore,
safely weaning the patient from the ventilator as soon as pos-
sible is paramount. Difﬁcult weaning is considered when the
patients fail initial weaning and require up to three spontane-
ous breathing trials (SBT)or as long as 7 days from the ﬁrst
SBT to achieve successful weaning. Weaning attempts that
are repeatedly unsuccessful usually signify incomplete resolu-
tion of the illness that precipitated mechanical ventilation, or
the development of one or more new problems.3,4
The indications for invasive mechanical ventilation in pa-
tients with acute respiratory failure include apnea or impend-
ing respiratory arrest, acute exacerbation of chronic
obstructive pulmonary disease with dyspnea, tachypnea and
acute respiratory acidosis, plus one of the following (acute car-
diovascular instability, altered mental status, or persistent
uncooperativeness, inability to protect the lower airway, copi-
ous or unusually viscous secretions, abnormalities of the face
or upper airway preventing effective ventilation, progressive
respiratory acidosis or other deterioration despite intensive
therapy. Invasive mechanical ventilation should be considered
when PaO2 remains <45 mm Hg despite maximum tolerated
fraction of inspired oxygen, or pH remains <7.20. Other
causes include acute ventilatory insufﬁciency in neuromuscular
diseases, in the presence of acute respiratory acidosis, progres-
sive decline in vital capacity to less than 10–15 mL/kg, progres-
sive decline in maximum inspiratory pressure to less than 20–
30 cm H2O. Acute hypoxemic respiratory failure with tachyp-
nea, respiratory distress, and persistent hypoxemia despite
administration of high fraction of inspired oxygen via high
ﬂow system, or in the presence of any of the following (acute
cardiovascular instability, altered mental status or persistent
uncooperativeness, inability to protect the lower airway).
Other causes include the need for endotracheal intubation to
maintain or protect the lower airway or to manage secretions,
especially in patients with an endotracheal tube with an inter-
nal diameter of 68 mm.5
There are innumerable factors responsible for failure of
weaning from mechanical ventilation. Pulmonary factors that
should be considered in all difﬁcult-to-wean patients include
ventilator settings, infections, airway patency, posture, andrespiratory muscle performance. Malnutrition, which is com-
mon in ventilator-dependent patients, has detrimental effects
on the respiratory system. Heart failure or coronary ischemia
can be induced by the reduction of ventilatory support and
cause weaning failure. A number of electrolyte imbalances
can impact the process of weaning from mechanical ventila-
tion. Psychological problems (e.g. anxiety) can be an impedi-
ment to successful weaning.5,6
Neuromuscular dysfunctions acquired during ICU stay are
considered to be one of the important factors that impair the
weaning process. Up to 62% of difﬁcult-to-wean patients,
who do not have preexisting neurologic disorders, show evi-
dence of neuromuscular dysfunction that is signiﬁcant enough
to account for these patients’ persistent respiratory failures.7
Ventilator-induced diaphragm dysfunction and critical illness
oxidative stress are deﬁned as loss of diaphragm force-generat-
ing capacity that is speciﬁcally related to use of controlled
mechanical ventilation.8 Critical illness neuromuscular abnor-
malities (CINMA) are the most common peripheral neuro-
muscular disorders encountered in the intensive care unit
(ICU) setting and usually involve both muscle and nerve.9
The pathophysiology of the neuromuscular dysfunction is
attributed to the depressed central drive, central ventilatory
command which leads to the failure of the neuromuscular
respiratory system and the peripheral dysfunction which is
considered the primary cause of neuromuscular weakness; crit-
ical illness neuromuscular abnormalities (CINMA). Liberation
from mechanical ventilation requires the resumption of neuro-
muscular activity to overcome the impedance of the respira-
tory system, to meet metabolic demands and to maintain
carbon dioxide homeostasis. This requires an adequate signal
generation in the central nervous system, intact transmission
to spinal respiratory motor neurons, respiratory muscles and
neuromuscular junctions. Disruption of any portion of this
transmission may contribute to weaning failure.10 Central
drive may be impeded by metabolic alkalosis, mechanical ven-
tilation itself or the use of sedative/hypnotic medications.10
The importance of the contribution of daily awakening and
heightened awareness over sedation to prolonged weaning
and ICU stay has been established in the literature.11 Failure
of the neuromuscular respiratory system to maintain homeo-
stasis results in an increased central drive to breathe, which
in turn may cause ventilatory failure. This pattern may be ob-
served in response to an increased resistive load from upper
airway obstruction, an imbalance between mechanical load
and respiratory muscle capacity or isolated muscle weakness.
Neuromuscular dysfunction associated with delayed weaning 225Abnormalities of upper airway motor control are potential
causes of extubation failure. These neuromuscular disorders
may be common and have been reported in up to 62% of pa-
tients in some studies.12 Primary causes of neuromuscular
weakness such as Guillain–Barre´ syndrome, myasthenia gravis
and motor neuron disease are usually apparent before weaning
difﬁculties are encountered. However, occasionally these new
diagnoses will be made in the course of investigating the difﬁ-
cult-to-wean patient. Most neuromuscular dysfunction that
complicates weaning is acquired during the ICU stay.10
CINMA are the most common peripheral neuromuscular
disorders encountered in the ICU setting and usually involve
both muscle and nerve.9 These disorders were ﬁrst described
in Canada and France in 1984.13,14 The reported prevalence
of CINMA in the literature has varied between 50–100%
and this has been associated with severity of illness, multiple
organ dysfunction, exposure to corticosteroids, presence of
hyperglycemia and prolonged ICU stay.15,16 CINMA pre-
sents as a motor deﬁcit where muscle weakness is bilateral,
symmetrical and most marked in the proximal muscles. Elec-
troneuromyographic studies of the limbs show sensorimotor
axonopathy with preserved velocities and the decreased
amplitude of compound action potentials. Neuromuscular
transmission is normal except in the case of prolonged neuro-
muscular blockade. In patients with severe muscle involve-
ment, decreased motor action potentials and ﬁbrillation
potentials may resemble a motor axonopathy and a true dis-
tinction between a nerve and/or muscle lesion may be difﬁ-
cult. Myopathy may be conﬁrmed on muscle biopsy and
type II ﬁber drop-out with a loss of myosin ﬁlaments is a
consistent ﬁnding.13,14
The most common form of intensive care unit (ICU)-ac-
quired myopathy is critical illness myopathy (CIM). This dis-
order is also known by other names, including acute
quadriplegic myopathy and thick ﬁlament myopathy. The
strongest risk factor for CIM is the use of IV glucocorticoids
in the ICU setting, and there is some correlation between the
likelihood of occurrence and severity of disease with glucocor-
ticoid dose. Associated and perhaps triggering factors may in-
clude a higher illness severity index, hyperglycemia,
hyperthyroidism, and possibly the systemic inﬂammatory re-
sponse syndrome.17
The major histopathologic ﬁnding in CIM is relatively the
selective loss of myosin, which can be identiﬁed as a lack of
reactivity to myosin ATPase in non-necrotic ﬁbers. This ﬁnd-
ing can be conﬁrmed with immunohistochemical studies for
myosin and by utilizing electron microscopy to identify the loss
of thick ﬁlaments. There is usually atrophy of myoﬁbers, type
2 more than type 1. There is often evidence of myoﬁbrillar dis-
organization, which may be partly manifested as abnormal
basophilic stippling on hematoxylin and eosin stains, purplish
staining with Gomori trichrome, and irregular clumping of the
reaction product with NADH-TR. Some degree of necrosis
may occur.18–20
Oxidative stress may also play a role in the development of
CIM, as illustrated by the ﬁnding that sarcolemmal immuno-
staining of the nitric oxide synthase isoform NOS1 was re-
duced or absent in six patients with CIM.21 While the
signiﬁcance of this ﬁnding is not clear, it is hypothesized that
the loss of sarcolemmal NOS1 could lead to muscle ﬁber in-
excitability by reducing nitric oxide release at the muscle
membrane.21The bedside evaluation of respiratory neuromuscular weak-
ness is difﬁcult. Maximum inspiratory pressure and vital
capacity are dependent on patient comprehension and cooper-
ation and are hindered by the endotracheal tube.22–24 In the
intubated patient maximal pressure generation can be assessed
during occluded maximal maneuvers and this can be simply
performed as the endotracheal tube is easily accessible.23,24
Subsequent investigators have not found (maximum inspira-
tory pressure (PImax) to provide such clear separation between
weaning success and weaning failure patients.22,25–32 Sensitiv-
ity was approximately 0.80, meaning that approximately
80% of patients who succeeded in a weaning trial had a PImax
value that predicted success (i.e., more negative than 30 cm
H2O). However, speciﬁcity was approximately 0.25, meaning
that only a minority (25%) of patients who failed a weaning
trial had a PImax that predicted weaning failure (i.e., less neg-
ative than 30 cm H2O). Moreover, the ability to predict out-
come was not improved by employing a standardized method
of measuring PImax. Based on these data, PImax measure-
ments appear to be more helpful in understanding the reason
why a particular patient failed a weaning trial rather than in
deciding whether to attempt a weaning trial.22,30
Twitch transdiaphragmatic pressure in response to bilateral
stimulation of the phrenic nerves can give a measure of dia-
phragmatic contractility. Clinical applicability is limited as this
requires the placement of both an esophageal and gastric bal-
loon. The airway pressure at the end of the tracheal tube in re-
sponse to phrenic nerve stimulation has been proposed to be a
noninvasive alternative measure and may have a role in mon-
itoring inspiratory muscle contractility as its correlation to
twitch transdiaphragmatic pressure is weak.33,34
The aim of this work: was to evaluate the role of the neuro-
muscular factors responsible for delay weaning from mechan-
ical ventilation.
2. Patients
The study included 19 patients with delay weaning from
mechanical ventilation from the Alexandria medical respira-
tory intensive care unit (ICU) during the period from May
2009 till May 2010. In revising the existing literature, this has
been deﬁned as >14 days,35 of mechanical ventilation. In the
present study, delay mechanical ventilation was considered as
duration P14 days. For those patients who failed weaning
after 14 days of MV, tracheostomy was done to guard against
the occurrence of complications as trachea–esophageal ﬁstula.
2.1. Selection criteria
– Patients who need mechanical ventilation for medical
reasons.5
– Patient fulﬁlling the parameters for weaning,10 with failed
spontaneous breathing trial.
2.2. Exclusion criteria
– Patients with central nervous system disorders as cerebro-
vascular stroke, brain tumors and encephalopathy.
226 Y. Khalil et al.– Traumatic lesions that necessitate mechanical ventilation.
– Post-operative patients who need mechanical ventilation.
– Patients less than eighteen year old.
– Patients who were discharged before seven days after the
ﬁrst attempt of weaning will be excluded from this study.
– Patients who are mechanically ventilated due to malignant
lung tumors either primary or secondary.
The primary diagnosis of the studied patients was as follows;
13 patients (42%) with acute exacerbation of Chronic Obstruc-
tive Pulmonary Diseases, ﬁve (16%) with Interstitial Lung Dis-
eases, four (13%) with Obesity Hypoventilation Syndrome,
three (10%)withObstructive SleepApneaHypopnea Syndrome
and Hypoventilation, two (6%) with ARDS, two (6%) with
bronchiectasis, one case (3%) with pulmonary embolism, and
one patient (3%) with thalassemia major and pleural effusion.
3. Methods
3.1. The following data were recorded on admission
3.1.1. Clinical evaluation
 History taking {name, age, sex, residency, occupation and
smoking history}.
 General examination.
 Vital signs (temperature, pulse, respiratory rate, and blood
pressure).
 Thorough chest examination.
 Neurological evaluation (Glasgow Coma Score).
 Assessment of BodyMass Index (BMI): weight/height in m2.Table 1 Age, sex, BMI and smoking of the studied patients.
Age (mean ± SD) 57.7 ± 15
Sex (No. and %)
Male 10 (52%)
Female 9 (48%)
BMI (mean ± SD) 30 ± 7.9
Smoking (No. and %)
Smokers 10 (48%)
Non-smokers 9 (52%)
SD: standard deviation, BMI: body mass index (kg/m2).3.1.2. Ventilator data
Data included tidal volume (ml/kg of predicted body weight),
respiratory rate, fractional inspired oxygen (FiO2), and inspi-
ratory ﬂow rate. Data were adjusted according to the diagnosis
of the patient to protect the lung from ventilator induced lung
injury. After correction of the initial cause of mechanical ven-
tilation, follow up routine laboratory investigations were done
(complete blood picture, serum K, serum Na, renal and hepa-
tic functions) for the assessment of readiness to wean from
mechanical ventilation. All the patients were put on pressure
support ventilation (PSV) mode of mechanical ventilation with
a gradual decrease of the pressure support then the patients are
reevaluated for readiness to wean from mechanical ventilation
using the following parameters:
– Arterial gasometry and acid –base state on PSV.
– PImax measurement: using a tube connected to a pressure
gauge through the endotracheal tube. The patient is asked
to do his maximal inspiratory effort and the pressure is
measured during brief occlusion of the airways. The test
was repeated several times to reach the best readings.
– Rapid shallow breathing index (RSBI): respiratory rate
divided by tidal volume (breaths/min per L).10
– Compliance-respiratory rate-arterial oxygenation-maxi-
mum inspiratory pressure index (CROP index.)22
– Physical examination to assess respiratory rate, paradoxical
motion of the rib cage and abdomen, recession of the supra-
sternal and intercostal spaces, and accessory muscle
recruitment.Neuromuscular evaluation: This was done after failure of
weaning on PSV and this included:
– Motor nerve conduction studies of median and peroneal
nerves and sensory nerve conduction studies of ulnar and
superﬁcial peroneal nerves as well as electromyogram
(EMG) of biceps, extensor digitorum, vastus medialis and
tibialis anterior muscles.
3.1.3. Assessment of some serum electrolytes
Potassium (k+), calcium (Ca+2), phosphorus (Ph) and magne-
sium (Mg) levels and evaluation of their relation with the neu-
romuscular ﬁndings.
4. Statistical analysis
Data were analyzed using the Statistical Package for Social
Sciences (SPSS ver.17 Chicago, IL, USA). Quantitative data
were described using median, minimum and maximum. Qual-
itative data were described using number and percent. Associ-
ation between 2 qualitative variables done using Chi-square
test and comparing quantitative variables between 2 groups
conducted using Mann Whitney U test.
5. Results
The Age, sex, BMI, smoking and co-morbid illness of the stud-
ied patients are shown in Table 1.
5.1. Neuromuscular dysfunctions and their relation to the
outcome and duration of mechanical ventilation
In the present study EMG and sensory–motor nerve conduc-
tion study was done in 19 cases. It was normal in 5 patients;
four (22%) were successfully weaned and one (5%) failed the
weaning trial and ﬁnally died. While in relation to the duration
of MV, two patients (10%) with normal study required a dura-
tion of MVP 14 days and 3 (17%) required < 14 days. Two
patients showed a picture of myopathy in EMG and nerve con-
duction study; both (10%) were successfully weaned and one
(5%) required a duration of MVP 14 days. In twelve patients
EMG and sensory–motor nerve conduction study showed a
picture of moderate-severe axonal sensory–motor peripheral
neuropathy. Eight patients (42%) were successfully weaned
and 4 (21%) failed weaning trials and ﬁnally died. While in
relation to the duration of MV, 10 (55%) required a duration
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Neuromuscular dysfunction associated with delayed weaning 227of MVP 14 days and 2 (10%) required < 14 days. There
were no signiﬁcant differences in the outcome and duration
of mechanical ventilation in relation to the presence of neuro-
muscular dysfunction using EMG and nerve conduction study,
(P> 0.05) (Table 2).
5.2. Relation between corticosteroid intake during ICU stay and
neuromuscular dysfunction
Among those cases that showed positive EMG and nerve con-
duction study (myopathy or peripheral neuropath); two
(14.3%) were not receiving corticosteroids, 5 (35.7%) received
corticosteroids for a duration of 14P days, and 7 (50%) re-
ceived corticosteroids for a duration <14 days While in pa-
tients with normal EMG and nerve conduction study, 2
(40%) received corticosteroids for a duration of P14 days
and 3 (60%) received corticosteroids for <14 days. There
was no signiﬁcant relationship between corticosteroids intake
and neuromuscular dysfunction proved by EMG and nerve
conduction study (P> 0.05) (Table 3).
5.3. Relation between serum albumin level, Mg, Ca, and Ph and
the neuromuscular dysfunction
Cases with normal EMG and nerve conduction study showed
mean serum albumin of 2.6 g/dl (median, 2.6; range, 2.5–2.8)
and in those with positive study either myopathy or peripheral
neuropathy, of 2.4 g/dl (median, 2.3; range, 2–3.4). There was
a statistically signiﬁcant relationship between serum albumin
level and neuromuscular dysfunction (p= 0.037). Mean of to-
tal serum Mg, total serum Ca, and serum Ph were [1.6 mg/dl
(median, 1.7; range, 1.1–1.9), 7.6 mg/dl (median, 7.6; range,
7–8.1), and 3.4 mg/dl (median, 3.4; range, 3–3.6) respectively]
in patients with normal EMG and nerve conduction study
and [1.4 mg/dl (median, 1.4; range, 1.1–2), 7.7 mg/dl (median,
7.7; range, 7–9), and 3.4 mg/dl (median, 3.5; range, 2.2–4.1)
respectively] in those with positive EMG and nerve conduction
study (myopathy or peripheral neuropathy). There was no sig-
niﬁcant relationship between serum Mg, Ca, and Ph and neu-
romuscular dysfunction (P> 0.05) (Table 4).
5.4. Relation between PImax measured during PSV and
neuromuscular dysfunctions proved by EMG and nerve
conduction study
Cases with normal EMG and nerve conduction study showed
mean PI max of 18 cm H2O (median, 16; range, 24 to
14), while those with positive study (myopathy or peripheral
neuropathy) showed mean PImax of 15 cm H2O (median,
14.5; range, 24 to 10). There was no statistical signiﬁcant
relationship between the value of PImax and the presence of
neuromuscular dysfunction (P> 0.05) (Table 5).
6. Discussion
The discontinuation or withdrawal process from mechanical
ventilation is an important clinical issue.36,37 Patients are gen-
erally intubated and placed on mechanical ventilators when
their own ventilatory and/or gas exchange capabilities are out-
stripped by the demands placed on them from a variety of dis-
eases. Mechanical ventilation also is required when the
Table 3 Relation between corticosteroids intake and neuromuscular dysfunction.
EMG and nerve
conduction
Corticosteroid intake Monte Carlo-Chi-
Square (P value)
Total
No
steroids
P14 days duration of
steroids intake
<14 days duration of
steroids intake
Normal study 0 (0%) 2 (10%) 3 (17%) 1.000 5 (27%)
Positive ﬁndings 2 (10%) 6 (32%) 7 (37%) 14 (73%)
Total 2 (10%) 8 (42%) 9 (48%) 19 (100%)
By Monte Carlo-Chi-Square test, P value < 0.05 represents signiﬁcant difference.
Table 4 Relation between the mean values of albumin, Mg, Ca, and Ph and neuromuscular dysfunctions.
Electromyography and nerve conduction ﬁndings Mann–Whitney Z (P)
Normal study (n:5) Myopathy or peripheral neuropathy (n:14)
Mean albumin g/dl Mean ± SD 2.6 ± 0.1 2.4 ± 0.3 0.037*
Median 2.6 2.3
Range 2.5–2.8 2–3.4
Mg (mg/dl) Mean ± SD 1.6 ± 0.4 1.4 ± 0.3 0.671
Median 1.7 1.4
Range 1.1–1.9 1.1–2
Ca (mg/dl) Mean ± SD 7.6 ± 0.4 7.7 ± 0.5 0.963
Median 7.6 7.7
Range 7–8.1 7–9
Ph (mg/dl) Mean ± SD 3.4 ± 0.2 3.4 ± 0.5 0.607
Median 3.4 3.5
Range 3–3.6 2.2–4.1
By Mann–Whitney-U test, P value < 0.05 represents signiﬁcant difference. Mg: magnesium, Ph: phosphorus, Ca: calcium.
* Denotes signiﬁcance.
Table 5 Showing relation between PImax and neuromuscular dysfunctions.
Mean PImax cm H2O EMG and nerve conduction ﬁndings Mann–Whitney Z (P)
Normal study (n:5) Myopathy or Peripheral neuropathy (n:14)
Mean ± SD 18 ± 4 15 ± 4.4 21 (0.192)
Median 16 14.5
Range 24 to 14 24 to 10
By Mann–Whitney-U test, P value < 0.05 represents signiﬁcant difference.
228 Y. Khalil et al.respiratory drive is incapable of initiating ventilatory activity,
either because of disease processes or drugs. As the conditions
that warranted placing the patient on the ventilator stabilize
and begin to resolve, attention should be placed on removing
the ventilator as quickly as possible. This process is termed
‘‘ventilator weaning’’ (implying a gradual process), or ‘‘discon-
tinuation’’. Weaning attempts that are repeatedly unsuccessful
usually signify incomplete resolution of the illness that precip-
itated mechanical ventilation, or development of one or more
new problems. All potential causes of ventilator dependency
should be identiﬁed when a patient is difﬁcult-to-wean. Then,
a plan should be developed that uses a multidisciplinary team
approach to correct the reversible causes of weaning failure
and facilitates weaning thereafter. Failure to wean has been
attributed to an imbalance between the load faced by the respi-
ratory muscles and their neuromuscular competence. Failure
to wean is usually multifactorial. The present study included31 patients with difﬁcult weaning from mechanical ventilation.
They are screened to indentify the risk factors responsible for
difﬁcult weaning. Among the studied patients, 16 (52%) were
males and 15 (48%) were female. Regarding smoking, 16 cases
(52%) were non-smokers and 15 (48%) were smokers.
In revising the existing literature, PMV has been variously
deﬁned as >24 h,38,39 >2 days,40 >14 days,35 or >29 days41
of mechanical ventilation or, alternatively, the need for post-
ICUs mechanical ventilator support.42,43 In the present study,
prolonged mechanical ventilation was considered as duration
P14 days. With follow up of our studied patients; 18 (58%)
were successfully weaned and 13 (42%) failed weaning trials
and ﬁnally died. Other studies found that, hospital survival
for adult PMV patients in the short-term acute care (STAC)
hospital setting ranges from 39% to 75%, depending on the
patient population and deﬁnition for PMV.39 and hospital sur-
vival in various non-STAC hospital settings varies from 50%
Neuromuscular dysfunction associated with delayed weaning 229in many series44–50 to as high as 94%, depending in part on
admission criteria and likelihood of transfer to a different facil-
ity when patients become acutely ill. Difﬁcult weaning from
mechanical ventilation proved to be multifactorial.
Regarding the outcome of mechanical ventilation after cor-
rection of the detected problems; eighteen patients (58%) were
successfully weaned from mechanical ventilation and thirteen
(42%) failed several weaning trials and ﬁnally died. There
was no signiﬁcant relation between the primary diagnosis
and the outcome of mechanical ventilation, (p= 0.5). This
may be due to small sample size. Similar ﬁndings were reported
by Richard et al.51 who studied 95 patients; the cause of respi-
ratory failure was judged to be the exacerbation of chronic
obstructive pulmonary disease (COPD) (49%), pneumonia
(20%), pulmonary edema (7%), surgery (11%) and others
(13%). They found no statistically signiﬁcant relationship be-
tween the cause of acute respiratory failure and the outcome
of mechanical ventilation. In the present study, 60% of the
cases with interstitial lung disease failed weaning trials and ﬁ-
nally died. Infections were important risk factors for difﬁcult
weaning that developed in all the studied cases with interstitial
lung disease either pulmonary or extra-pulmonary. Also the
study revealed other factors as malnutrition in 100%, psycho-
logical problems in 80%, cardiovascular dysfunctions in 80%,
electrolyte disturbances in 60%, neuromuscular dysfunctions
proved by EMG and nerve conduction studies in 50% and
other factors such as renal and hepatic impairment were de-
tected in 20% of the cases. In a study adopted by Paone
et al.52 that retrospectively analyzed 34 consecutive idiopathic
pulmonary ﬁbrosis patients undergoing mechanical ventilation
for acute respiratory failure, ﬁve patients (15%) survived and
were discharged; one patient was still alive after 1 year. The
in-hospital mortality rate observed in this study was different
than Ferna´ndez-Pe´rez and co-workers’53 results (85% vs.
60%), but consistent with previous observations by Fumeaux
et al.54 The cause for high mortality rate among cases with
interstitial lung disease may be due to being of idiopathic pul-
monary ﬁbrosis type as they have little or no recruitable lung
and may be susceptible to over-distension of the relatively in-
tact lung when high positive end pulmonary expiratory pres-
sure levels are used during mechanical ventilation, leading to
ventilator-induced lung injury.
There were no signiﬁcant relationships between the age,
gender of the studied patients and the outcome and duration
of mechanical ventilation (p> 0.05). Our observations were
in accordance with the work of Richard et al.51 who studied
95 patients with acute respiratory failure, their mean ages were
69.6 ± 9.3, 52.6% were male and 47.3% were female. They
found no statistical signiﬁcant relationships between the age,
gender and the outcome of mechanical ventilation.
As much as overweight and weaning failure is concerned, in
the present study 12 studied patients were obese (BMIP 30);
11 (63%) required long duration of MVP 14 days and 7
(47%) failed weaning trials and died at the end but there
was no signiﬁcant relationship between high BMI and the out-
come and duration of MV (P> 0.05). O’Brien et al.,55 in a
secondary analysis of the data for the ARDS Network trials
of mechanical ventilation, reported that the duration of
mechanical ventilation was similar for overweight and obese
patients compared with the normal body weight group (18.5–
24.9 kg m2). Similar ﬁndings were reported by Tremblay
and Bandi.56 who looked at the effect of obesity on the lengthof ICU stay, which was increased, but the duration of mechan-
ical ventilation was not.
6.1. Neuromuscular dysfunction and difﬁcult weaning from MV
Patients receiving prolonged mechanical ventilation and other
forms of critical care support commonly suffer from acquired
neuromuscular disorders. Although MV may be prolonged by
the occurrence of neuromuscular abnormalities, neuromuscu-
lar involvement also may be facilitated by prolonged MV. In
the present work; EMG and nerve conduction study was done
in 19 cases with difﬁcult weaning. The results showed 26%
with a normal picture, 63% with moderate to severe axonal
sensory–motor peripheral neuropathy and 10.5% with a pic-
ture of myopathy. De Jonghe et al.16 reported that neuromus-
cular weakness is a common occurrence in patients who are
critically ill, developing in P25% of patients who are in the
intensive care unit (ICU) and ventilated for at least seven days.
They reported, 4 independent variables associated with the
occurrence of clinical motor weakness. The number of days
with dysfunction in at least two organs before awakening
was signiﬁcantly higher in ICU acquired paresis patients than
in the controls, suggesting that the duration, rather than the
severity, of multiple-organ dysfunction plays a signiﬁcant role
in ICU acquired paresis. They found a strong association be-
tween the administration of corticosteroids and the occurrence
of ICU acquired paresis. The duration of mechanical ventila-
tion before awakening was also signiﬁcantly associated with
the occurrence of ICU acquired paresis. Surprisingly, female
sex was found to be independently associated with a higher
rate of ICU acquired paresis in their study. Regarding using
maximal inspiratory pressure to assess respiratory muscle
strength in the ICU, measurement of PImax is difﬁcult and
it is measured by brieﬂy occluding the airway at end-expiratory
volume. Jonathan et al. reported that neuromuscular weakness
can be identiﬁed and quantiﬁed by measuring a maximal in-
spired pressure (should be <30 cm H2O).57 In the present
study measurement of maximum inspiratory pressure to the
studied cases revealed that it is less negative in patients with
neuromuscular disorders than those without (mean was
15 cm H2O vs. 18 cm H2O, respectively) yet; the difference
was not statistically signiﬁcant (p= 0.192). Concerning the
relation between neuromuscular dysfunctions and the duration
of MV, in the present study 50% of the cases with myopathy
and 83% with polyneuropathy required a duration of mechan-
ical ventilationP 14 days (p= 0.184). Garnacho-Montero
et al.58 evaluated septic patients receiving ventilation for at
least 7 days for CIP (critical illness polyneuropathy). Patients
with electrophysiologic evidence of CIP had a longer duration
of mechanical ventilation than patients without (median,
34 days vs. 14 days; p< 0.001). This ﬁnding was explained
by a longer period required for weaning and was associated
with an increased length of ICU and hospital stay. Similar
ﬁndings were reported in a study adopted by De Jonghe
et al.9 They evaluated ICU patients receiving ventilation for
at least 7 days who were sufﬁciently awake to permit evalua-
tion for ICU-acquired paresis. Of the 95 patients enrolled, 24
patients (25%) had ICU-acquired paresis. The weak patients
exhibited a similarly increased period of weaning and the dura-
tion of mechanical ventilation as compared to the non-weak
cohort. Regarding the effect of neuromuscular dysfunctions
on the outcome of MV, in the present study, 33% of the pa-
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died (p= 0.798). Garnacho-Montero et al.59 studied a popula-
tion of severely ill patients: septic patients with multiple organ
dysfunction syndrome requiring mechanical ventilation for
>10 days. Patients with CIP (Critical illness polyneuropathy)
had higher in-hospital mortality rates than those without CIP
(84% vs. 56.5%, p= 0.01). Similarly, Leijten et al.60 found
that in 50 patients receiving mechanical ventilation for
>7 days, ICU mortality was higher in the CIP group (48%
vs. 19%, p= 0.03). As much as Drug intake and its effect
on the occurrence of neuromuscular dysfunction is concerned,
many medications have been implicated as causes of weakness.
The role of corticosteroids in CINM is particularly controver-
sial. Corticosteroids, the most widely studied,16,61,62 have a sig-
niﬁcant association with the development of ICU-acquired
weakness. In animal models, administration of corticosteroids
can produce selective muscle atrophy, particularly of fast-
twitch ﬁbers.63 However, a thick ﬁlament myopathy identical
to CIM can be best produced by combining denervation injury
and corticosteroids.64 In such an animal model, complete loss
of muscle excitability was found, that was ascribed to the inac-
tivation of fast sodium channels.65.
In the present study 35.7% of cases with EMG and sen-
sory–motor nerve conduction study abnormalities (myopathy
or peripheral neuropathy) received corticosteroids for duration
P14 days (in the form of Dexamethazone in 60% and Predni-
sone in 40%). Statistically, there was no signiﬁcant relation be-
tween the duration of corticosteroids intake and the
occurrence of CINMA (p= 1.000). Among the studies with
a multivariate analysis of risk factors for CINM, De Jonghe
et al.,16 Herridge et al.,62 and Campellone et al.66 concluded
to a deleterious effect of corticosteroids. Whereas several data
indicate that moderate doses of steroids do not prolong
mechanical ventilation due to muscle weakness but are related
to signiﬁcantly more ventilator-free days and earlier spontane-
ous breathing capacity.67Another study showed that low-dose
hydrocortisone application does not provoke impaired muscle
membrane excitability, suggesting that steroid involvement in
CIM development is dose dependent.68 Concerning electro-
lytes disturbance as risk factors for neuromuscular dysfunc-
tions, hypophosphatemia, hypomagnesaemia and
hypocalcaemia are considered important contributing factors
for myopathy and neuropathy. Phosphorus is the major intra-
cellular anion. Approximately 85% of total body phosphorus
is contained in bone. Phosphorus is used for cell membranes
and is essential for adenosine triphosphate and red blood cell
2,3-diphosphoglyceric acid synthesis. It also plays a role in
the regulation of glycolysis, ammonia genesis, and calcium reg-
ulation.69 Consequently, hypophosphatemia leads to decreased
oxygen delivery to tissues (including the central nervous sys-
tem), and rarely to hemolysis in severe cases. Myocardial
and skeletal muscle contractility also may be altered which re-
sults in symptomatic muscle weakness, respiratory failure, and
difﬁculty in weaning from mechanical ventilation. In the pres-
ent study, mean serum phosphorus was 3.4 ± 0.5 mg/dl
among cases with neuromuscular dysfunctions and
3.4 ± 0.2 mg/dl among those without, there was no signiﬁcant
statistical relation between serum phosphorus level and neuro-
muscular dysfunctions, (p= 0.607). Asymptomatic presenta-
tion of the studied cases with neuromuscular dysfunctions
may be due to near normal serum phosphorus levels. This goes
in agreement with Bugg and Jones70 who reported that symp-toms of muscle weakness mostly occur in severe hypophospha-
temia, deﬁned as a serum phosphate concentration that is less
than 0.32 mmol/L, but can also be present in moderate cases
(0.32–0.8 mmol/L). Regarding magnesium; it is an essential
cofactor of ATP reactions. This divalent cation also is involved
in DNA replication and transcription, and translation of
mRNA.71 Consequently, hypomagnesaemia may have deleteri-
ous effects on energy production and protein metabolism. Ser-
um contains only 0.3% of total body magnesium, and
therefore, is a poor reﬂection of total stores. In addition, stan-
dard assays measure total serum magnesium; however, almost
the entire ionized portion (corresponding to nearly 67% of to-
tal) is metabolically active.72 Ionized magnesium can be mea-
sured by ion-selective electrodes; however, such analyzers are
not widely available. In the present study mean of total serum
Mg level was 1.6 mg/dl (median, 1.7; range, 1.1–1.9) for pa-
tients with normal EMG and nerve conduction study, and
1.4 mg/dl (median, 1.4; range, 1.1–2) for those with EMG
and nerve conduction abnormalities (myopathy or peripheral
neuropathy), p= 0.671. Dhingra et al.73 had evaluated the ef-
fects of hypomagnesaemia on respiratory muscle strength in 11
patients admitted to the ICU with chronic obstructive pulmon-
ary disease. They found that infusion of 6 g of magnesium in-
creased PEmax by 24 percent and Plmax by 46 percent.
Regarding calcium, the present work revealed no signiﬁcant
difference in serum calcium among cases with neuromuscular
dysfunctions and those without (mean was 7.7and 7.6, respec-
tively), p= 0.963. This study clariﬁes the relation between
hypophosphatemia, hypomagnesaemia, and hypocalcaemia
and neuromuscular dysfunctions showing that early diagnosis
of electrolytes disturbances may be of help in the management
of neuromuscular disorders acquired during ICU stay. Several
studies have demonstrated marked increase in diaphragmatic
strength immediately following repletion of Ca, Ph, and Mg,
suggesting that the deﬁciencies impair the contractile proper-
ties of the diaphragm.73,74 Concerning serum albumin and its
relation to neuromuscular dysfunctions, in the present work
mean serum albumin level was 2.4 g/dl among cases with neu-
romuscular dysfunction and 2.6 g/dl among those without,
there was a signiﬁcant relationship between hypoalbuminemia
and neuromuscular dysfunction (p= 0.037). In agreement
with our ﬁndings William E. Mitch75 reported that low values
of serum albumin are closely related to the presence of inﬂam-
mation and loss of muscle mass is attributable to the activation
of speciﬁc proteases. Also Nanas et al.76 found that low serum
albumin <3.5 mg/dl and mean daily serum glucose >150 mg/
dl are predictive of critical illness polyneuropathy.
Any exposure to exogenous corticosteroids during the ICU
stay might cause muscle weakness and possibly contribute to
the duration of mechanical ventilation. In the present study,
15 patients received corticosteroids for a duration P14 days;
7 (46.7%) failed weaning trials and 12 (80%) required a dura-
tion of MVP 14 days (p> 0.05). In one outcome study of
survivors of ARDS, Herridge et al.62 reported that the absence
of corticosteroids was associated with a better functional out-
come. Similar ﬁndings were reported by Amaya-Villar et al.61
who observed that higher doses of steroids than those recom-
mended for physiological replacement therapy are associated
with severe myopathy that will prolong the duration of
mechanical ventilation. This study together with the others
gives a proof that some medications used for the management
of respiratory failure may themselves be responsible for difﬁ-
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tion. So revising drug therapy used in the management of
the patient in ICU during mechanical ventilation should be
part of the general protocol applied for detection of the cause
of difﬁcult weaning.
The present study stresses on the importance of neuromus-
cular assessment in all cases with difﬁcult weaning as this may
be an important contributing factor for difﬁcult weaning and
prolonged mechanical ventilation (neuropathic or myopathic
in origin). EMG and nerve conduction study may be of help
for the detection of such disturbances. So, proper assessment
of the neuromuscular apparatus and the management of any
disorder may be a great step toward successful weaning. Eval-
uation of the neuromuscular factors should be put into consid-
eration in every patient attending the ICU. Finally still there
are risk factors for difﬁcult weaning from mechanical ventila-
tion that need to be assessed and obviously there is still scope
for further investigation of difﬁcult weaning from MV and this
promises to be an exciting area of research in the future.
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